INVISALIGN SYSTEM
Report
- Report Number
- 2953749-2011-00109
- Event Type
- Other
- Date Received
- August 25, 2011
- Date of Event
- August 12, 2011
- Report Date
- August 23, 2011
- Manufacturer
- ALIGN TECHNOLOGY, INC.
- Product Code
- NXC
- PMA / PMN Number
- K081960
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- DENTIST
Narratives
THE ALIGNERS ARE NOT BEING EVALUATED (METHOD) AS THE PRODUCT PERFORMED IN ACCORDANCE TO SPECIFICATIONS (RESULTS, CONCLUSION) AND THE DEVICE WAS USED IN ACCORDANCE WITH LABELED INDICATIONS (RESULTS). THE PTS SYMPTOMS OF SWOLLEN LIPS AND TONGUE ARE NOT CONSIDERED TO BE SERIOUS IN NATURE, BUT COULD BE AN INDICATOR OF AN ALLERGIC REACTION. NO CONCLUSIVE EVIDENCE HAS BEEN PROVIDED THAT SUPPORTS OR OPPOSES THE FACT THAT THE INVISALIGN PRODUCT CAUSE OR CONTRIBUTED TO THE PT SYMPTOMS. SINCE THE INVISALIGN PRODUCT WAS BEING USED AT THE TIME OF THE REPORTED SYMPTOMS. THE TREATING DOCTOR BELIEVE THE EVENT COULD HAVE BEEN SERIOUS OR LIFE THREATENING TO THE PT, THUS AN MDR IS BEING REPORTED.
ON (B)(6) 2011, THE TREATING DR. REPORTED THAT THE PT STARTED TREATMENT ON (B)(6) 2011 AND 4 DAYS AFTER WEARING ALIGNER STAGE #1, THE PT REPORTED FEELING SWOLLEN LIPS AND TONGUE. SYMPTOMS STARTED GRADUALLY. THE PT THOUGH THE SYMPTOMS WERE NORMAL AND HE KEPT WEARING THE ALIGNERS. TWELVE DAYS LATER THE SYMPTOMS BECAME WORSE. THE PT STOPPED USING THE ALIGNERS AND TOOK BENADRYL TO ALLEVIATE THE REPORTED SYMPTOMS AND FELT BETTER. THE TREATING DR. SAW THAT THE PT WAS HAVING REDNESS, ULCERATION ON HIS LIPS AND EDEMA ON HIS MOUTH. THE TREATING DR. CONFIRMED IT WAS AN ALLERGIC REACTION. THE TREATING DOCTOR BELIEVE THE EVENT COULD HAVE BEEN SERIOUS OR LIFE THREATENING TO THE PT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | INVISALIGN SYSTEM | SEQUENTIAL ALIGNERS - ORTHODONTIC DEVICE | NXC | ALIGN TECHNOLOGY, INC. | INVISALIGN FULL | 92239501 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 38 YR | Other |